✦ LIBER ✦

Risk Factors for Pneumocystis jirovecii Pneumonia in Patients With Lymphoproliferative Disorders

✍ Scribed by Karam M. Obeid; Javier Aguilar; Susan Szpunar; Mamta Sharma; Ramon del Busto; Ayad Al-Katib; Leonard B. Johnson

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Primary Prophylaxis for Pneumocystis jir

✍ Passawee Vananuvat; Parawee Suwannalai; Somnuek Sungkanuparph; Ticha Limsuwan; P 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 199 KB

High Prevalence of Dihydropteroate Synth

✍ Dini, L.; du Plessis, M.; Frean, J.; Fernandez, V. 📂 Article 📅 2010 🏛 American Society for Microbiology 🌐 English ⚖ 73 KB

Low prevalence of Pneumocystis jirovecii

✍ Steve M. Taylor; Steven R. Meshnick; William Worodria; Alfred Andama; J. Lucian 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 178 KB

Risk factors for Pneumocystis jirovecii

✍ M.G.J. de Boer; F.P. Kroon; S. le Cessie; J.W. de Fijter; J.T. van Dissel 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 212 KB

The rate of Pneumocystis jirovecii pneum

✍ M.F. Sheikholeslami; J. Sadraei; P. Farnia; M. Forouzandeh Moghadam; H. Emadikoc 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 100 KB

Differences in the clinical characterist

✍ Tatsuji ENOMOTO; Arata AZUMA; Ayumi KOHNO; Kazuyo KANEKO; Hitoshi SAITO; Minako 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 140 KB